.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Find suppliers and generic API sources

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Healthtrust
Deloitte
Cipla
Dow
Julphar
Colorcon
Chubb
AstraZeneca

Generated: July 21, 2017

DrugPatentWatch Database Preview

DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE Drug Profile

« Back to Dashboard

Which patents cover Dexbrompheniramine Maleate And Pseudoephedrine Sulfate, and when can generic versions of Dexbrompheniramine Maleate And Pseudoephedrine Sulfate launch?

Dexbrompheniramine Maleate And Pseudoephedrine Sulfate is a drug marketed by Avanthi Inc and is included in one NDA.

The generic ingredient in DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE is dexbrompheniramine maleate; pseudoephedrine sulfate. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dexbrompheniramine maleate; pseudoephedrine sulfate profile page.

Summary for Tradename: DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list105,157
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avanthi Inc
DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE
dexbrompheniramine maleate; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL078648-001Feb 27, 2013OTCNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Daiichi Sankyo
Citi
Express Scripts
Colorcon
McKesson
UBS
QuintilesIMS
US Army
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot